Advertisement

Individual and Joint Effects of Pulse Pressure and Blood Pressure Treatment Intensity on Serious Adverse Events in the SPRINT Trial

      Abstract

      Purpose

      The objective of this study was to determine individual and joint effects of pulse pressure and blood pressure treatment intensity on serious adverse events in the Systolic Blood Pressure Intervention Trial.

      Methods

      Pulse pressure was calculated by subtracting diastolic blood pressure from systolic blood pressure. Blood pressure treatment intensity goal was ≤140 mm Hg in the control arm and ≤120 mm Hg in the intensive arm. The primary outcome was a 5-point composite of hypotension, syncope, electrolyte abnormalities, acute renal insufficiency, or injurious falls.

      Results

      In 9361 trial participants, the incident rate for the primary outcome per 1000 person-years increased with higher pulse pressure category: ≤49 mmHg: 20.4 (17.2-24.1), 50-59 mmHg: 24.5 (21.3-28.2), 60-69 mmHg: 31.7 (27.7-36.2), ≥70 mmHg: 44.6 (39.8-49.9; Ptrend < .0001; hazard ratio [HR] of pulse pressure [every 10 mm Hg] 1.23; 95% confidence interval [CI], 1.18-1.28). The intensive treatment arm had a higher incidence rate of serious adverse events than the control arm (34.2, 95% CI, 31.2-37.3, vs 26.0, 95% CI, 23.4-28.8, P = .0001; HR 1.32; 95% CI, 1.15-1.51). The combined effect was not significant in the relative risk scale (HR 0.97, Pinteraction = .48) but was significant in the risk difference scale (P = .027), contributing 2.5 additional serious adverse events per 1000 person-years for every 10 mm Hg increase in pulse pressure in excess of the individual effects of pulse pressure and treatment intensity.

      Conclusions

      Wider pulse pressure and intensive blood pressure treatment were individually associated with the composite adverse event outcome. A modest effect modification of pulse pressure and treatment intensity led to additional adverse events when both were present. Clinicians should use caution when treating older patients with elevated pulse pressure to an intensive blood pressure treatment target.

      KEYWORDS

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Selvaraj S
        • Steg PG
        • Elbez Y
        • et al.
        Pulse pressure and risk for cardiovascular events in patients with atherothrombosis: from the REACH registry.
        J Am Coll Cardiol. 2016; 67: 392-403
        • Franklin SS
        • Wong ND
        Pulse pressure: how valuable as a diagnostic and therapeutic tool?.
        J Am Coll Cardiol. 2016; 67: 404-406
        • Whelton PK
        • Carey RM
        • Aronow WS
        • et al.
        2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        J Am Coll Cardiol. May 2018; 71https://doi.org/10.1016/j.jacc.2017.11.006
        • SPRINT Research Group
        • Wright Jr, JT
        • Williamson JD
        • et al.
        A randomized trial of intensive versus standard blood-pressure control.
        N Engl J Med. 2015; 373: 2103-2116
        • Franklin SS
        • Jacobs MJ
        • Wong ND
        • L'Italien GJ
        • Lapuerta P
        Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III.
        Hypertension. 2001; 37: 869-874
        • Darne B
        • Girerd X
        • Safar M
        • Cambien F
        • Guize L
        Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality.
        Hypertension. 1989; 13: 392-400
        • Glynn RJ
        • Chae CU
        • Guralnik JM
        • Taylor JO
        • Hennekens CH
        Pulse pressure and mortality in older people.
        Arch Intern Med. 2000; 160: 2765-2772
        • Williamson JD
        • Supiano MA
        • Applegate WB
        • et al.
        Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial.
        JAMA. 2016; 315: 2673-2682
        • Karayiannis C
        • Phan TG
        • Srikanth V
        Intensive vs standard blood pressure control for older adults.
        JAMA. 2016; 316: 1920-1921
        • Kim DH
        Intensive vs standard blood pressure control for older adults.
        JAMA. 2016; 316 (1921)
        • Bavishi C
        • Bangalore S
        • Messerli FH
        Outcomes of intensive blood pressure lowering in older hypertensive patients.
        J Am Coll Cardiol. 2017; 69: 486-493
        • Ambrosius WT
        • Sink KM
        • Foy CG
        • et al.
        The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).
        Clin Trials. 2014; 11: 532-546
        • Vandenbroucke JP
        • von Elm E
        • Altman DG
        • et al.
        Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.
        PLoS Med. 2007; 4: e297
        • Knol MJ
        • VanderWeele TJ
        Recommendations for presenting analyses of effect modification and interaction.
        Int J Epidemiol. 2012; 41: 514-520
        • Knol MJ
        • van der Tweel I
        • Grobbee DE
        • Numans ME
        • Geerlings MI
        Estimating interaction on an additive scale between continuous determinants in a logistic regression model.
        Int J Epidemiol. 2007; 36: 1111-1118
        • Li R
        • Chambless L
        Test for additive interaction in proportional hazards models.
        Ann Epidemiol. 2007; 17: 227-236
        • VanderWeele TJ
        • Knol MJ
        A tutorial on interaction.
        Epidemiol Method. 2014; 3: 33-72
        • Vittinghoff E
        • Glidden GV
        • Shioshki SC
        • McCulloch CE
        Regression Methods in Biostatistics .
        2nd ed. Springer, New York, NY2012
        • Statalist
        Implementation of additive interactions in Cox proportional hazards model?.
        (Available at:Accessed January 8) (Accessed January 8)
        • Burt VL
        • Whelton P
        • Roccella EJ
        • et al.
        Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991.
        Hypertension. 1995; 25: 305-313
        • Franklin SS
        • Gustin 4th, W
        • Wong ND
        • et al.
        Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study.
        Circulation. 1997; 96: 308-315
        • Rothman KJ
        • Greenland S
        • Lash TL
        Modern Epidemiology.
        3rd ed. Lippincott Williams & Wilkins;, Baltimore, MD2008
        • de Mutsert R
        • Jager KJ
        • Zoccali C
        • Dekker FW
        The effect of joint exposures: examining the presence of interaction.
        Kidney Int. 2009; 75: 677-681
        • Hosmer DW
        • Lemeshow S
        Confidence interval estimation of interaction.
        Epidemiology. 1992; 3: 452-456
        • Hallan S
        • de Mutsert R
        • Carlsen S
        • Dekker FW
        • Aasarod K
        • Holmen J
        Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable?.
        Am J Kidney Dis. 2006; 47: 396-405
        • Peralta CA
        • Jacobs Jr, DR
        • Katz R
        • et al.
        Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA).
        Am J Kidney Dis. 2012; 59: 41-49
        • Shimbo D
        • Barrett Bowling C
        • Levitan EB
        • et al.
        Short-term risk of serious fall injuries in older adults initiating and intensifying treatment with antihypertensive medication.
        Circ Cardiovasc Qual Outcomes. 2016; 9: 222-229
        • Krishnaswami A
        • Alloggiamento T
        • Forman DE
        • Leong TK
        • Go AS
        • McCulloch CE
        Association of age to mortality and repeat revascularization in end-stage renal disease patients: implications for clinicians and future health policies.
        Perm J. 2016; 20: 4-9
        • Altman DG
        • Lausen B
        • Sauerbrei W
        • Schumacher M
        Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.
        J Natl Cancer Inst. 1994; 86: 829-835
        • Vogeli C
        • Shields AE
        • Lee TA
        • et al.
        Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs.
        J Gen Intern Med. 2007; 22: 391-395
        • Dimitri M
        • Janus E
        • Karunajeewa H
        Intensive vs standard blood pressure control for older adults.
        JAMA. 2016; 316: 1921-1922
        • Andersson C
        • Vasan RS
        Intensive vs standard blood pressure control for older adults.
        JAMA. 2016; 316: 1922-1923
        • Richman IB
        • Fairley M
        • Jorgensen ME
        • Schuler A
        • Owens DK
        • Goldhaber-Fiebert JD
        Cost-effectiveness of intensive blood pressure management.
        JAMA Cardiol. 2016; 1: 872-879
        • Patel KK
        • Arnold SV
        • Chan PS
        • et al.
        Personalizing the intensity of blood pressure control: modeling the heterogeneity of risks and benefits from SPRINT (Systolic Blood Pressure Intervention Trial).
        Circ Cardiovasc Qual Outcomes. 2017 Apr; 10: e003624https://doi.org/10.1161/CIRCOUTCOMES.117.003624
        • Tinetti ME
        • Naik AD
        • Dodson JA
        Moving from disease-centered to patient goals-directed care for patients with multiple chronic conditions: patient value-based care.
        JAMA Cardiol. 2016; 1: 9-10